{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:36:31Z","timestamp":1778596591057,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is not a prevailing consensus on appropriate antibiotic choice, route, and duration in the treatment of bacterial pleural empyema after appropriate source control. Professional society guidelines note the lack of comparative trials with which to guide recommendations. We assessed clinical outcomes in the treatment of known and suspected empyema based upon three aspects of antibiotic use: (1) total duration, (2) duration of intravenous (IV) antibiotics, and (3) duration of anti-anaerobic antibiotics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a hypothesis-generating retrospective chart review analysis of 355 adult inpatients who had pleural drainage, via either chest tube or surgical intervention, for known or suspected empyema. The primary outcome variable was clinician assessment of resolution or lack thereof. The secondary outcomes were death within 90 days, hospital readmission within 30 days for empyema, and all-cause hospital readmission within 30 days. Mann-Whitney U test was used to compare outcomes with regard to these variables.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>None of the independent variables was significantly associated with a difference in clinical resolution rate despite trends for total antibiotic duration and anti-anaerobic antibiotic duration. None of the independent variables was associated with mortality. Longer total antibiotic duration was associated with lower readmission rate for empyema (median 17 [interquartile range 11\u201328] antibiotic days in non-readmission group vs. 13 [6-15] days in readmission group), with a non-significant trend for all-cause readmission rate (17 [11\u201328] days vs. 14 [9\u201321] days). IV antibiotic duration was not associated with a difference in any of the defined outcomes. Longer duration of anti-anaerobic antibiotics was associated with both lower all-cause readmission (8.5 [0\u201317] vs. 2 [0\u201311]) and lower readmission rate for empyema (8 [0\u201317] vs. 2 [0\u20133]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data support the premise that routine use of anti-anaerobic antibiotics is indicated in the treatment of pleural empyema. However, our study casts doubt on the benefits of extended IV rather than oral antibiotics in the treatment of empyema. This represents a target for future investigation that could potentially limit complications associated with the excessive use of IV antibiotics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07759-8","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T17:03:23Z","timestamp":1665594203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of antibiotic use and clinical outcomes in adults with known and suspected pleural empyema"],"prefix":"10.1186","volume":"22","author":[{"given":"Benjamin S.","family":"Avner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anush","family":"Ginosyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeena","family":"Qiryaqoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuyler","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"7759_CR1","first-page":"914","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, ninth edition","author":"M Parta","year":"2020","unstructured":"Parta M. Pleural effusion and empyema. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, ninth edition. Philadephia: Elsevier; 2020. pp.\u00a0914\u201325."},{"issue":"2","key":"7759_CR2","first-page":"ii41","volume":"65","author":"HE Davies","year":"2010","unstructured":"Davies HE, Davies RJ, Davies CW, Group, BTS Pleural Disease Guideline. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65 Suppl 2:ii41\u201353.","journal-title":"Thorax"},{"issue":"6","key":"7759_CR3","doi-asserted-by":"publisher","first-page":"e129-46","DOI":"10.1016\/j.jtcvs.2017.01.030","volume":"153","author":"KR Shen","year":"2017","unstructured":"Shen KR, Bribriesco A, Crabtree T, Denlinger C, Eby J, Eiken P, Jones DR, Keshavjee S, Maldonado F, Paul S, Kozower B. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153(6):e129-46.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"7759_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.arbres.2015.01.009","volume":"51","author":"L Ferreiro","year":"2015","unstructured":"Ferreiro L, San Jos\u00e9 ME, Vald\u00e9s L. Management of parapneumonic pleural effusion in adults. Arch Bronconeumol. 2015;51(12):637\u201346.","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"7759_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1055\/s-0039-1694699","volume":"40","author":"MS Godfrey","year":"2019","unstructured":"Godfrey MS, Bramley KT, Detterbeck F. Medical and surgical management of empyema. Semin Respir Crit Care Med. 2019;40(3):361\u201374.","journal-title":"Semin Respir Crit Care Med"},{"key":"7759_CR6","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.2147\/IJGM.S292705","volume":"14","author":"M Hassan","year":"2021","unstructured":"Hassan M, Patel S, Sadaka AS, Bedawi EO, Corcoran JP, Porcel JM. Recent insights into the management of pleural infection. Int J Gen Med. 2021;14:3415\u201329.","journal-title":"Int J Gen Med"},{"issue":"5","key":"7759_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jinf.2016.02.009","volume":"72","author":"K Birkenkamp","year":"2016","unstructured":"Birkenkamp K, O\u2019Horo JC, Kashyap R, Kloesel B, Lahr BD, Daniels CE, Nichols FC 3rd, Baddour LM. Empyema management: A cohort study evaluating antimicrobial therapy. J Infect. 2016;72(5):537\u201343.","journal-title":"J Infect"},{"issue":"3","key":"7759_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/00365548.2010.536162","volume":"43","author":"CN Meyer","year":"2011","unstructured":"Meyer CN, Rosenlund S, Nielsen J, Friis-M\u00f8ller A. Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis. 2011;43(3):165\u20139.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"7759_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12890-018-0726-1","volume":"18","author":"CN Meyer","year":"2018","unstructured":"Meyer CN, Armbruster K, Kemp M, Thomsen TR, Dessau RB, Danish Pleural Empyema Group. Pleural infection: a retrospective study of clinical outcome and the correlation to known etiology, co-morbidity and treatment factors. BMC Pulm Med. 2018;18(1):160.","journal-title":"BMC Pulm Med"},{"issue":"7","key":"7759_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.200601-074OC","volume":"174","author":"NA Maskell","year":"2006","unstructured":"Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174(7):817\u201323.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"7759_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ccm.2021.08.001","volume":"42","author":"DN Addala","year":"2021","unstructured":"Addala DN, Bedawi EO, Rahman NM. Parapneumonic effusion and empyema. Clin Chest Med. 2021;42(4):637\u201347.","journal-title":"Clin Chest Med"},{"issue":"2","key":"7759_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.anaerobe.2011.12.004","volume":"18","author":"JG Bartlett","year":"2012","unstructured":"Bartlett JG. Anaerobic bacterial infection of the lung. Anaerobe. 2012;18(2):235\u20139.","journal-title":"Anaerobe"},{"issue":"4","key":"7759_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4103\/0255-0857.118902","volume":"31","author":"G Senol","year":"2013","unstructured":"Senol G, Coskun M, Gunduz A, Bicmen C, Tibet G. Anaerobes in nosocomial and community acquired pleural infections. Indian J Med Microbiol. 2013;31(4):392\u20134.","journal-title":"Indian J Med Microbiol"},{"issue":"5","key":"7759_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.anaerobe.2004.06.001","volume":"10","author":"L Boyanova","year":"2004","unstructured":"Boyanova L, Djambazov V, Gergova G, Dragomir Iotov, Petrov D, Osmanliev D, Minchev Z, Mitov I. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. Anaerobe. 2004;10(5):261\u20137.","journal-title":"Anaerobe"},{"issue":"1","key":"7759_CR15","doi-asserted-by":"publisher","first-page":"20190027","DOI":"10.1515\/pp-2019-0027","volume":"5","author":"JM Porcel","year":"2020","unstructured":"Porcel JM, Ferreiro L, Rumi L, Espino-Pais\u00e1n E, Civit C, Pardina M, Schoenenberger-Arnaiz JA, Vald\u00e9s L, Bielsa S. Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial. Pleura Peritoneum. 2020;5(1):20190027.","journal-title":"Pleura Peritoneum"},{"issue":"7","key":"7759_CR16","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","volume":"53","author":"JS Bradley","year":"2011","unstructured":"Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT, Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25\u201376.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"7759_CR17","doi-asserted-by":"publisher","first-page":"e20161692","DOI":"10.1542\/peds.2016-1692","volume":"138","author":"SS Shah","year":"2016","unstructured":"Shah SS, Srivastava R, Wu S, Colvin JD, Williams DJ, Rangel SJ, Samady W, Rao S, Miller C, Cross C, Clohessy C, Hall M, Localio R, Bryan M, Wu G, Keren R. Pediatric Research in Inpatient Settings Network. Intravenous versus oral antibiotics for postdischarge treatment of complicated pneumonia. Pediatrics. 2016;138(6):e20161692.","journal-title":"Pediatrics"},{"issue":"12","key":"7759_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1542\/hpeds.2015-0100","volume":"5","author":"C Stockmann","year":"2015","unstructured":"Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, Korgenski EK, Hersh AL. Comparative effectiveness of oral versus outpatient parenteral antibiotic therapy for empyema. Hosp Pediatr. 2015;5(12):605\u201312.","journal-title":"Hosp Pediatr"},{"issue":"1","key":"7759_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/INF.0000000000002872","volume":"40","author":"WJ Svetanoff","year":"2021","unstructured":"Svetanoff WJ, Dorman RM, Dekonenko C, Osuchukwu O, Jain S, Depala K, Myers A, Oyetunji TA, St Peter SD. Protocol-driven antibiotic treatment of pediatric empyema after fibrinolysis. Pediatr Infect Dis J. 2021;40(1):44\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"7759_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/000313481608200412","volume":"82","author":"CM Espinosa","year":"2016","unstructured":"Espinosa CM, Fallat ME, Woods CR, Weakley KE, Marshall GS. An Approach to the Management of pleural empyema with early video-assisted thoracoscopic surgery and early transition to oral antibiotic therapy. Am Surg. 2016;82(4):295\u2013301.","journal-title":"Am Surg"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07759-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07759-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07759-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T17:03:28Z","timestamp":1665594208000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07759-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7759"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07759-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project involved collection of existing clinical data with no additional contact with subjects. In order to anonymize data before its use, patient identifiers were destroyed after chart extraction and prior to data analysis. Consent was waived by the Western Michigan University Homer Stryker MD School of Medicine IRB per the United States Department of Health & Human Services regulation 45 CFR Part 46.104(d) under category 4 (iii). The use of the data for this research is also regulated under 45 CFR 164.512(i)(2)(ii), therefore a waiver of HIPA authorization was also granted for this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This statement confirms that all methods were carried out in accordance with institutional policies governing human subjects research at Western Michigan University Homer Stryker MD School of Medicine. This information can be accessed on the medical school website.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"783"}}